Citations

Citations to this article as recorded by  

• Predicting BRCA mutation and stratifying targeted therapy response using multimodal learning: a multicenter study
  Yi Li, Xiaomin Xiong, Xiaohua Liu, Mengke Xu, Boping Yang, Xiaoju Li, Yu Li, Bo Lin, Bo Xu
  Annals of Medicine.2024;[Epub]     CrossRef
• Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next‐generation sequencing in Ramathibodi Hospital, Mahidol University
  Songporn Oranratnachai, Watchalawalee Yamkaew, Atchara Tunteeratum, Thongchai Sukarayothin, Nareenart Iemwimangsa, Ravat Panvichien
  Cancer Reports.2023;[Epub]     CrossRef
• Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations
  Clement Chung, Vanessa T.Y. Yeung, Kenneth C.W. Wong
  Journal of Oncology Pharmacy Practice.2023; 29(6): 1343.     CrossRef
• Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
  Jinyong Kim, Kyeonghun Jeong, Hyeji Jun, Kwangsoo Kim, Jeong Mo Bae, Myung Geun Song, Hanbaek Yi, Songyi Park, Go-un Woo, Dae-Won Lee, Tae-Yong Kim, Kyung-Hun Lee, Seock-Ah Im
  Human Genomics.2023;[Epub]     CrossRef
• BRCA 1–2 Incidence in Synchronous and Metachronous Breast Cancer: a Tertiary Center Study
  Ahmet Dağ, Bilal Arslan, Erkan Güler, Serdar Mermer
  Indian Journal of Surgery.2022;[Epub]     CrossRef
• Habitat Analysis of Breast Cancer-Enhanced MRI Reflects BRCA1 Mutation Determined by Immunohistochemistry
  Tianming Du, Haidong Zhao, Chen Li
  BioMed Research International.2022; 2022: 1.     CrossRef
• Prevalence and Factors Associated with BRCA1/2 Gene Mutation in Chinese Populations with Breast Cancer
  Guoding Huang, Hongquan Lu, Qizhu Chen, Xinting Huang
  International Journal of General Medicine.2022; Volume 15: 6783.     CrossRef
• Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis
  Xiaojing Liu, Jing Yue, Ruqiya Pervaiz, Hanwang Zhang, Lan Wang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Relationship between Baseline [18F]FDG PET/CT Semiquantitative Parameters and BRCA Mutational Status and Their Prognostic Role in Patients with Invasive Ductal Breast Carcinoma
  Francesco Dondi, Domenico Albano, Pietro Bellini, Luca Camoni, Giorgio Treglia, Francesco Bertagna
  Tomography.2022; 8(6): 2662.     CrossRef
• The clinical and diagnostic characteristics of BRCA-associated breast cancer
  M.A. Golotyuk, A.A. Berezhnoy, N.V. Kazantseva, A.V. Dorofeev, S.A. Shevchenko, I.V. Borzunov, N.I. Rozhkova
  Onkologiya. Zhurnal imeni P.A.Gertsena.2022; 11(6): 18.     CrossRef
• The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis
  Ilary Ruscito, Maria Luisa Gasparri, Maria Paola De Marco, Flavia Costanzi, Aris Raad Besharat, Andrea Papadia, Thorsten Kuehn, Oreste Davide Gentilini, Filippo Bellati, Donatella Caserta
  Cancers.2021; 13(6): 1391.     CrossRef
• Changing Patterns in Clinicopathological Characteristics of Breast Cancer and Prevalence of BRCA Mutations: Analysis in a Rural Area of Southern China
  Qiuming Wang, Heming Wu, Yongquan Lan, Jinhong Zhang, Jingna Wu, Yunuo Zhang, Liang Li, Donghua Liu, Jinfeng Zhang
  International Journal of General Medicine.2021; Volume 14: 7371.     CrossRef

Phyllodes tumor is an uncommon fibroepithelial neoplasm of the breast. And it is characterized by expanded stroma with increased cellularity and elongated epithelium-lined clefts. Mammary carcinomas within phyllodes tumors have been rarely reported. To date, however, no reports have described the invasive cribriform carcinoma arising in malignant phyllodes tumor. Here, we report a 62-year-old woman who presented with a large breast mass. Microscopically, the mass was a typical malignant phyllodes tumor showing well developed leaf-like architecture and stromal overgrowth with high cellularity and nuclear pleomorphism. In a portion of the tumor, however, the epithelial component showed a cribriform pattern of proliferation in the absence of myoepithelial cells, suggestive of the invasive cribriform carcinoma. To our knowledge, this is rare and it is difficult to make a differential diagnosis of it. Here, we report our case with a review of literatures.

Citations

Citations to this article as recorded by  

• Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma
  Jie Jane Chen, Iowis Zhu, Akshat Patel, Gregor Krings, Yunn-Yi Chen, Florence Yuen, Rita A. Mukhtar, Michelle Melisko, Lisa Singer, Catherine C. Park, Nicolas D. Prionas
  Advances in Radiation Oncology.2024; 9(5): 101448.     CrossRef
• High-grade ductal carcinoma in-situ detected by microcalcification within borderline phyllodes tumor: Report of a case and literature review
  Wing Nam Yuen, Joshua J.X. Li, Man Yi Chan, Gary M. Tse
  Human Pathology Reports.2023; 31: 300697.     CrossRef
• Cribriform carcinoma arising in a benign phyllodes tumor
  Elia Shazniza Shaaya, Nurwahyuna Rosli, Nurismah M D Isa
  Journal of Research in Medical Sciences.2023;[Epub]     CrossRef
• Unexpectedly High Coexistence Rate of In Situ/Invasive Carcinoma In Phyllodes Tumors. 10-Year Retrospective and Review Study
  Öykü Dila Gemci, Serdar Altınay, Rümeysa İlbar Tartar, Sina Ferahman
  European Journal of Breast Health.2022; 18(4): 343.     CrossRef
• A Case of Phyllodes Tumor Combined with Lobular Carcinoma of the Breast with Microinvasion
  Daiki IMANISHI, Satoru NODA, Tsutomu TAKASHIMA, Yukie TAUCHI, Shinya NOMURA, Hiroshi OHTANI, Noriko SAKAIDA
  Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2022; 83(12): 2049.     CrossRef
• Invasive ductal carcinoma within borderline phyllodes tumor with lymph node metastases: A case report and review of the literature
  DI WU, HAIPENG ZHANG, LIANG GUO, XU YAN, ZHIMIN FAN
  Oncology Letters.2016; 11(4): 2502.     CrossRef